|
UMPS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.163200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.264000E-01 |
| Normal-vs-Stage2 |
4.129900E-02 |
| Normal-vs-Stage3 |
2.174400E-01 |
| Normal-vs-Stage4 |
2.330200E-01 |
| Stage1-vs-Stage2 |
2.025600E-02 |
| Stage1-vs-Stage3 |
1.250370E-01 |
| Stage1-vs-Stage4 |
1.225390E-01 |
| Stage2-vs-Stage3 |
4.250400E-01 |
| Stage2-vs-Stage4 |
4.343600E-01 |
| Stage3-vs-Stage4 |
9.748000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.998200E-01 |
| Normal-vs-AfricanAmerican |
2.489600E-01 |
| Normal-vs-Asian |
1.500210E-01 |
| Caucasian-vs-AfricanAmerican |
5.082400E-01 |
| Caucasian-vs-Asian |
5.090800E-01 |
| AfricanAmerican-vs-Asian |
6.744200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.206470E-02 |
| Normal-vs-Female |
7.326000E-02 |
| Male-vs-Female |
1.92498999999069E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.423000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.267600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.681040E-01 |
| Normal-vs-Age(81-100Yrs) |
8.801200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.007600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.274800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.405700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.471200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.788300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.632300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.056300E-02 |
| Normal-vs-Grade 2 |
9.850200E-01 |
| Normal-vs-Grade 3 |
1.896020E-01 |
| Normal-vs-Grade 4 |
1.382640E-01 |
| Grade 1-vs-Grade 2 |
2.430600E-01 |
| Grade 1-vs-Grade 3 |
1.102000E-01 |
| Grade 1-vs-Grade 4 |
3.422500E-02 |
| Grade 2-vs-Grade 3 |
1.861190E-01 |
| Grade 2-vs-Grade 4 |
1.384650E-01 |
| Grade 3-vs-Grade 4 |
4.826600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.238180E-01 |
| Normal-vs-ccB subtype |
5.482100E-02 |
| ccA subtype-vs-ccB subtype |
1.037940E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.544400E-01 |
| Normal-vs-N1 |
6.177800E-01 |
| N0-vs-N1 |
4.083000E-01 |
|
|
